CryoCath to Hold Third Quarter 2008 Conference Call and Webcast
    Toronto Stock Exchange Symbol: CYT

    MONTREAL, July 30 /CNW/ - CryoCath (TSX: CYT), will hold a conference
call to discuss its third quarter 2008 financial results at 9:00 a.m. (Eastern
Time) on Tuesday, August 5, 2008. The call will be hosted by Mr. Jan Keltjens,
President and CEO and Mrs. Ginette Gagné, CFO. The Company will report its
results in a press release to be issued at 7:00 a.m on Tuesday, August 5.

    DATE:                 Tuesday, August 5, 2008

    TIME:                 9:00 a.m., Eastern Time

    DIAL IN NUMBER:       416-644-3427 or 1-866-250-4892

    TAPED REPLAY:         416-640-1917 or 1-877-289-8525

    REFERENCE NUMBER:     21279395 followed by the number sign

    WEBCAST:              A live audio webcast of the call will be available
                          at Webcast attendees are welcome
                          to listen to the conference in real-time or
                          on-demand at their convenience. The webcast will be
                          archived for 365 days. Please connect to this
                          website at least 15 minutes prior to the conference
                          call to ensure adequate time for any software
                          download that may be needed to hear the webcast.

    A question and answer session will follow, at which time the operator
will direct participants as to the correct procedure for submitting questions.

    About CryoCath

    CryoCath - - is a medical technology company that leads
the world in cryotherapy products to treat cardiac arrhythmias. With a
priority focus on providing physicians with a complete solution of catheter
products to treat cardiac arrhythmias, CryoCath has multiple products approved
in the U.S., across Europe and several ROW countries. The Company is
developing additional products to expand its pipeline of products to treat
cardiac arrhythmias.

    This press release includes "forward-looking statements" that are subject
to risks and uncertainties, including with respect to the timing of regulatory
trials and their outcome. For information identifying legislative or
regulatory, economic, climatic, currency, technological, competitive and other
important factors that could cause actual results to differ materially from
those anticipated in the forward looking statements, see CryoCath's annual
report available at under the heading Risks and Uncertainties in
the Management's Discussion and Analysis section.

    %SEDAR: 00015053EF

For further information:

For further information: visit our website at, or
contact: Ross Marshall, Investor Relations, Phone: (416) 815-0700 ext. 238,
Fax: (416) 815-0080, E-mail:

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890